Los Angeles, United States
Bionaut Labs, founded in 2016 and headquartered in the United States, is at the forefront of healthcare innovation with its Bionauts™, remote-controlled micro-robots. The company's pioneering technology is transforming the treatment of central nervous system disorders by enabling safe and precise targeting of deep brain structures.
Their slogan, "Precision micro-technology, the future of healthcare," encapsulates their mission to revolutionize medical intervention. As a cutting-edge entity in the healthcare technology sector, Bionaut Labs represents a pivotal development, capturing the attention of key industry investors.
The most recent financial boost came in the form of a $43.20M Series B investment, closed on 01 November 2022. Esteemed investors including Gaingels, Khosla Ventures, Bold Capital Partners, Whatif Ventures, and Sixty Degree Capital underscore the company's potential to redefine treatment approaches in critical neurological applications.
